Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta‐analysis is a research paper published in American Journal of Hematology (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cancer Prevention and Research Institute of Texas
Grant: CPRIT FP9178
Cancer Prevention and Research Institute of Texas
Grant: CPRIT RR190077
National Cancer Institute
Grant: NCI K08CA263313
National Cancer Institute
Grant: NCI L30CA253796
National Institutes of Health
Grant: P30 CA016672
NCI NIH HHS
Grant: K08 CA241318
NCI NIH HHS
Grant: K08 CA263313
NCI NIH HHS
Grant: L30 CA253796
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 5K08CA263313-03
Impact of clonal hematopoiesis mutations on toxicity and outcomes following oncologic therapy
FWCI
2.24
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals